when epirubicin was tested vs doxorubicin , both response rate ( 13 of 21 or 62 % vs 11 of 21 or 52 % ) and median response duration ( 11 months vs 13 months ) were comparable .
C0014582
epirubicin
C0013089
doxorubicin